ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

JANX Company Profile and Key Details

NASDAQ : JANX

Janux Therapeutics, Inc.

$30.68

-0.67-213.70%

At Close 4:00 PM

59.77

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

JANX Stock Price Chart

Stock Price Today

Janux Therapeutics, Inc. (JANX) stock declined over -213.72%, trading at $30.68 on NASDAQ, down from the previous close of $31.35. The stock opened at $31.77, fluctuating between $30.61 and $32.29 in the recent session.

Stock Snapshot

31.35

Prev. Close

31.77

Open

1.81B

Market Cap

59.11M

Number of Shares

30.605

Day Low

32.29

Day High

-23.97

P/E Ratio

83.21%

Free Float in %

-1.28

EPS (TTM)

7.38

Book Value

-1.12

Cash Flow per Share

699.06K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 14, 2025	31.77	32.38	30.60	30.68	683.15K
Mar 13, 2025	31.73	32.29	30.64	31.35	457.19K
Mar 12, 2025	29.60	31.98	29.30	31.81	928.7K
Mar 11, 2025	30.43	30.67	28.92	29.25	938.36K
Mar 10, 2025	31.26	31.39	29.51	30.22	859.56K
Mar 07, 2025	30.65	31.47	30.43	30.64	656.7K
Mar 06, 2025	30.78	31.36	30.21	30.75	1.03M
Mar 05, 2025	30.30	31.63	29.63	31.50	1.47M
Mar 04, 2025	31.51	32.00	29.63	29.99	1.77M
Mar 03, 2025	32.53	33.49	31.36	31.83	867K
Feb 28, 2025	32.37	33.30	31.96	32.89	979.9K
Feb 27, 2025	32.39	34.08	31.99	32.01	425.14K
Feb 26, 2025	32.91	33.76	32.22	32.60	749.43K
Feb 25, 2025	33.29	33.40	31.69	32.69	1.55M
Feb 24, 2025	36.07	36.25	33.49	33.58	1.3M
Feb 21, 2025	37.83	38.42	35.53	36.01	668.2K
Feb 20, 2025	37.27	37.90	36.52	37.17	691.12K
Feb 19, 2025	36.74	37.54	36.13	37.33	481.23K
Feb 18, 2025	36.61	38.13	36.20	37.09	580.49K
Feb 14, 2025	37.51	38.07	35.90	36.37	1.13M

Contact Details

La Jolla, CA 92037

United States

Website: https://www.januxrx.comContact: 858 750 4700

About Company

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.

Frequently Asked Questions

What is the current Janux Therapeutics, Inc. (JANX) stock price?

Janux Therapeutics, Inc. (NASDAQ: JANX) stock price is $30.68 in the last trading session. During the trading session, JANX stock reached the peak price of $32.29 while $30.61 was the lowest point it dropped to. The percentage change in JANX stock occurred in the recent session was -2.14% while the dollar amount for the price change in JANX stock was -$0.67.

JANX's industry and sector of operation?

The NASDAQ listed JANX is part of Biotechnology industry that operates in the broader Healthcare sector. Janux Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of JANX?

Ms. Brenda Van Vreeswyk
Head of HR
Mr. Tighe M. Reardon C.F.A., C.P.A., CPA
Acting Chief Financial Officer
Dr. David Alan Campbell Ph.D.
Pres, Chief Executive Officer & Director
Dr. Wayne Godfrey M.D.
Chief Medical Officer
Mr. Tommy Diraimondo Ph.D.
Senior Director of Research
Mr. Tighe M. Reardon C.F.A., CPA, CPA
Acting Chief Financial Officer
Mr. James Pennington
Gen. Counsel
Mr. Charles M. Winter
Senior Vice President of Chemistry, Manufacturing & Controls
Mr. Andy Hollman Meyer
Chief Bus. Officer
Mr. Byron Robinson J.D., Ph.D.
Chief Strategy Officer

How JANX did perform over past 52-week?

JANX's closing price is 6.09% higher than its 52-week low of $28.92 where as its distance from 52-week high of $71.71 is -57.22%.

How many employees does JANX have?

Number of JANX employees currently stands at 81.

Link for JANX official website?

Official Website of JANX is: https://www.januxrx.com

How do I contact JANX?

JANX could be contacted at phone 858 750 4700 and can also be accessed through its website. JANX operates from 11099 North Torrey Pines Road, La Jolla, CA 92037, United States.

How many shares of JANX are traded daily?

JANX stock volume for the day was 699.06K shares. The average number of JANX shares traded daily for last 3 months was 968.17K.

What is the market cap of JANX currently?

The market value of JANX currently stands at $1.81B with its latest stock price at $30.68 and 59.11M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	81
Beta	3.22
Sales or Revenue	$8.08M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology